| Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration S Näkki, J Rytkönen, T Nissinen, C Florea, J Riikonen, P Ek, H Zhang, ... Acta biomaterialia 13, 207-215, 2015 | 73 | 2015 |
| Chlorin e6 functionalized theranostic multistage nanovectors transported by stem cells for effective photodynamic therapy S Nakki, JO Martinez, M Evangelopoulos, W Xu, VP Lehto, E Tasciotti ACS applied materials & interfaces 9 (28), 23441-23449, 2017 | 60 | 2017 |
| Tailored dual PEGylation of inorganic porous nanocarriers for extremely long blood circulation in vivo T Nissinen, S Nakki, H Laakso, D Kuciauskas, A Kaupinis, MI Kettunen, ... ACS applied materials & interfaces 8 (48), 32723-32731, 2016 | 48 | 2016 |
| Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib J Riikonen, A Correia, M Kovalainen, S Näkki, M Lehtonen, J Leppänen, ... Biomaterials 52, 44-55, 2015 | 48 | 2015 |
| Approaches to improve the biocompatibility and systemic circulation of inorganic porous nanoparticles K Tamarov, S Näkki, W Xu, VP Lehto Journal of Materials Chemistry B 6 (22), 3632-3649, 2018 | 43 | 2018 |
| Facile synthesis of biocompatible superparamagnetic mesoporous nanoparticles for imageable drug delivery T Nissinen, S Näkki, M Latikka, M Heinonen, T Liimatainen, W Xu, ... Microporous and mesoporous materials 195, 2-8, 2014 | 16 | 2014 |
| Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model D Lumen, S Näkki, S Imlimthan, E Lambidis, M Sarparanta, W Xu, ... Pharmaceutics 11 (12), 686, 2019 | 14 | 2019 |
| Designed inorganic porous nanovector with controlled release and MRI features for safe administration of doxorubicin S Näkki, JTW Wang, J Wu, L Fan, J Rantanen, T Nissinen, MI Kettunen, ... International journal of pharmaceutics 554, 327-336, 2019 | 14 | 2019 |
| Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis R Thapa, S Mondal, J Riikonen, J Rantanen, S Näkki, T Nissinen, ... PLoS Neglected Tropical Diseases 15 (6), e0009533, 2021 | 7 | 2021 |
| Removing siloxanes and hydrogen sulfide from landfill gases with biochar and activated carbon filters M Selenius, J Ruokolainen, J Riikonen, J Rantanen, S Näkki, VP Lehto, ... Waste Management 167, 31-38, 2023 | 2 | 2023 |
| Biocompatibility improvement of mesoporous silicon by PEGylation S Näkki Itä-Suomen yliopisto, 2013 | 1 | 2013 |
| In-111-radiolabeling of tri-PEGylated porous silicon nanoparticles and their in vivo evaluation in murine 4T1 breast cancer model D Lumen, S Nakki, S Imlimthan, E Lambidis, M Sarparanta, W Xu, ... JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 62, S377-S378, 2019 | | 2019 |
| Functionalization of porous silicon nanovectors for targeted cancer therapy S Näkki Itä-Suomen yliopisto, 2018 | | 2018 |
| King’s Research Portal S Näkki, J Wang, J Wu, L Fan, J Rantanen, T Nissinen, W Xu | | 2018 |
| Supplementary Materials: Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model D Lumen, S Näkki, S Imlimthan, E Lambidis, M Sarparanta, W Xu, ... | | |
| Improved Circulation Time of Imageable Mesoporous Silicon Nanocarrier VP Lehto, S Näkki, T Nissinen, J Riikonen, H Santos, H Zhang, ... | | |
Wujun XuAdjunct Professor, Univeristy of Eastern FinlandVerifierad e-postadress på uef.fi
